C85.73 Other specified types of non-Hodgkin's lymphoma, intra-abdominal lymph nodes

Name of the Condition

• Other specified types of non-Hodgkin's lymphoma, intra-abdominal lymph nodes
• C85.73

Summary

Other specified types of non-Hodgkin's lymphoma, intra-abdominal lymph nodes, is a subtype of non-Hodgkin lymphoma (NHL) involving the lymph nodes within the abdominal cavity. This code applies when the lymphoma type is known but not classified into a more specific subcategory, and the site of involvement is limited to intra-abdominal lymph nodes. NHL arises from abnormal lymphocyte growth in the lymphatic system, which is part of the immune system.

Causes

The exact cause of this condition is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in the abdomen
• Abdominal pain or discomfort
• Bloating or fullness
• Unexplained weight loss
• Fever, night sweats, or fatigue

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI scans) to identify enlarged lymph nodes, and biopsy of the affected tissue to confirm lymphoma type. Blood tests and additional imaging may be used to assess disease extent. Pathology reports and clinical correlation are essential for accurate classification.

Treatment Options

Treatment depends on the lymphoma subtype, stage, and patient health. Options may include chemotherapy, immunotherapy, targeted therapy, or radiation therapy. Treatment plans are individualized and often involve a multidisciplinary team to optimize outcomes.

Prognosis and Follow-Up

Prognosis varies based on lymphoma subtype, stage, and response to treatment. Regular follow-up with imaging and clinical assessments is important to monitor for recurrence or progression. Long-term surveillance may be recommended to detect late effects or secondary conditions.

Complications

Potential complications include organ damage from tumor growth, treatment-related side effects (e.g., infection risk, fatigue), and recurrence. Advanced disease may lead to systemic symptoms or impaired organ function.

Lifestyle & Prevention

While prevention is not always possible, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive chemical exposure) may support overall health. Prompt medical attention for persistent symptoms is advised.

When to Seek Professional Help

Seek medical care if you experience persistent abdominal swelling, unexplained weight loss, fever, or other concerning symptoms. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Use C85.73 for other specified types of non-Hodgkin's lymphoma when the site is intra-abdominal lymph nodes and the lymphoma type is known but not classified into a more specific subcategory. Ensure documentation supports the intra-abdominal site and confirms the lymphoma type is not assigned to a more precise code. Verify that the diagnosis aligns with clinical findings and pathology reports.